FratFiles

• Save Paper

Eli Lilly and Company is one of the world’s top pharmaceutical companies, and is located in the United States. Their main competitors in the United States are Johnson and Johnson Corporation and Pfizer Incorporated. All three companies specialize in the manufacturing of pharmaceutical and medical products.
Using the financial ratios to analyze Eli Lilly’s competitive position, it is apparent that in most cases the company comes in second place with regards to its top 2 competitors. The short term solvency ratios indicate the liquidity of the company by comparing the current assets of the company with the current liabilities as a means to show how easily they can pay off their debts. Specifically Eli Lilly has a better current ratio than both companies, and a quick ratio that is better than Johnson and Johnson but only slightly worse than Pfizer.
Other ratios to consider when comparing the Eli Lilly with its competitors are the activity ratios, which show how the assets are......

View the rest of this paper...

Approximate Word Count: 689
Approximate Pages: 3 (250 words per double-spaced page)

Similar Essays

1. Financial Comparison Of Eli Lilly &Amp; Competitors
   

   Financial Comparison Of Eli Lilly & Competitors Eli Lilly and Company is one of the world's top pharmaceutical companies, and is located in the United States. Their main

2. Mr.
   

   are not diversified. They are either concentrated exclusively on pharmaceutical products (Eli Lilly and AstraZeneca are good examples with virtually 100% of their revenues coming

3. Forces And Trends Paper
   

   are taking this threat from the generic players quite seriously by spending more on R& D. Eli Lilly stood out as the largest spender of R&D in 2005 with its spending of 20.7% of

4. Pfizer's Operations In Europe
   

   and we market our medicines in 143 countries. In Ireland, Lilly has three operations: Eli Lilly and Company ( Ireland) Ltd. based in Dublin, is responsible for the marketing

5. Pepcid Case Study
   

   the existing OTC market and provide a great opportunity to attract non Pepcid AC users. Financial Analysis Both Merck and Johnson & Johnson are two big and financial sound